Inhibikase Therapeutics shares owned by Bank of New York Mellon
Quarter-by-quarter ownership of Inhibikase Therapeutics (IKT) shares owned by Bank of New York Mellon
from 13F filings
Historical chart of Bank of New York Mellon investment in Inhibikase Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Inhibikase Therapeutics held by Bank of New York Mellon consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Inhibikase Therapeutics by Bank of New York Mellon
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $282k | 138k | 2.05 |
| 2025-09-30 | $225k | 139k | 1.62 |
| 2025-06-30 | $258k | 133k | 1.95 |